The interplay between the tau protein and Aβ is revealing more than casual in AD [134,135], and the search of the cross-interaction sites on both proteins may lead to the design of new molecules capable of inhibiting cross-seeded toxic aggregation [136]. Here, MAPT is linked to Alzheimer disease.